Document is current
Any future updates will be listed below
-
Authors
Wang, Bangchen
Cardona, Diana M.
Huang, Jiaoti
- License Information
-
More Information
Article History
Received: 3 November 2024
Accepted: 27 March 2025
First Online: 11 April 2025
Declarations
:
: This study was approved by the Duke University Institutional Review Board (exempt review) and was performed in accordance with the Helsinki declaration.
: Not applicable.
: Jiaoti Huang, MD PhD, is a consultant for or owns shares in the following companies: Amgen, Artera, Kingmed Diagnostics, Teddy Clinical Research Laboratories, MoreHealth, OptraScan, Genetron, York Biotechnology, Genecode, VIVA Biotech, Seagen Inc. and Sisu Pharma, and received grants from Zenith Epigenetics, BioXcel Therapeutics, Inc., Dracen Pharmaceuticals and Fortis Therapeutics.
